Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -9312.55% is in line with its 5-year average of -8983.21%, around the middle of its 5-year range (-20726.38%–-2445.84%).
15.45% above its 12-month average of -11014.49%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -11503.18%.
OPERATING MARGIN
-9312.55%
OPERATING MARGIN AVG TTM
-11014.49%
OPERATING MARGIN AVG 3Y
-9781.67%
OPERATING MARGIN AVG 5Y
-8983.21%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+15.45%
CURRENT VS 3Y AVG
+4.80%
CURRENT VS 5Y AVG
-3.67%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aclarion, Inc.
Market Cap
$6.74M
Operating Margin
-9312.55%
TTM Avg
-11014.49%
3Y Avg
-9781.67%
5Y Avg
-8983.21%
Market Cap
$6.76M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.72M
Operating Margin
-450.07%
TTM Avg
-699.99%
3Y Avg
-986.00%
5Y Avg
-5433.17%
Market Cap
$6.88M
Operating Margin
-5025.53%
TTM Avg
-3024.64%
3Y Avg
-1688.76%
5Y Avg
-1108.68%
Market Cap
$7.03M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-19.45%
5Y Avg
-19.45%
Market Cap
$6.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.34M
Operating Margin
-119.54%
TTM Avg
-108.09%
3Y Avg
-117.27%
5Y Avg
-99.55%
Market Cap
$6.10M
Operating Margin
-763.90%
TTM Avg
-929.35%
3Y Avg
-1043.46%
5Y Avg
-924.75%
Market Cap
$6.10M
Operating Margin
-43737.46%
TTM Avg
-33857.66%
3Y Avg
-147235.02%
5Y Avg
-109633.70%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclarion, Inc. (ACON) | $6.74M | -9312.55% | -11014.49% | -9781.67% | -8983.21% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -450.07% | -699.99% | -986.00% | -5433.17% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -5025.53% | -3024.64% | -1688.76% | -1108.68% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | 0.00% | 0.00% | -19.45% | -19.45% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biomerica, Inc. (BMRA)vs › | $6.34M | -119.54% | -108.09% | -117.27% | -99.55% |
| Femasys Inc. (FEMY)vs › | $6.10M | -763.90% | -929.35% | -1043.46% | -924.75% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -43737.46% | -33857.66% | -147235.02% | -109633.70% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 0.00% | 0.00% | 0.00% | -71.62% |
Gross Margin
-291.3%
Operating Margin
-9312.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -11503.18% |
| 2026-03-31 | -14129.33% |
| 2025-12-31 | -10785.18% |
| 2025-09-30 | -9666.16% |
| 2025-06-30 | -8988.60% |
| 2025-03-31 | -7855.96% |
| 2024-12-31 | -17652.66% |
| 2024-09-30 | -8995.34% |
| 2024-06-30 | -10350.57% |
| 2024-03-31 | -12609.32% |
| 2023-12-31 | -8163.66% |
| 2023-09-30 | -6095.86% |
| 2023-06-30 | -8236.88% |
| 2023-03-31 | -4637.86% |
| 2022-12-31 | -5891.45% |
| 2022-09-30 | -8963.12% |
| 2022-06-30 | -20726.38% |
| 2022-03-31 | -8565.26% |
| 2021-12-31 | -8922.24% |
| 2021-09-30 | -7337.83% |
| 2021-06-30 | -2445.84% |
| 2021-03-31 | -3893.00% |
| 2020-12-31 | -4552.26% |
| 2020-09-30 | -10448.79% |
| 2020-06-30 | -10338.57% |
| 2020-03-31 | -10338.57% |
